Quick Answer
Quoin Pharmaceuticals, Ltd. reported Net Income of -$15.80 million for fiscal year 2025.
Quoin Pharmaceuticals, Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$15.80M | -76.3% |
| 2024 | -$8.96M | -3.2% |
| 2023 | -$8.69M | +7.4% |
| 2022 | -$9.38M | +56.3% |
| 2021 | -$21.46M | -924.3% |
| 2020 | -$2.10M | -34.3% |
| 2019 | -$1.56M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.95M | -68.0% | -6.8% |
| June 30, 2025 | -$3.70M | -87.2% | +3.0% |
| March 31, 2025 | -$3.81M | -63.8% | -62.2% |
| September 30, 2024 | -$2.35M | -22.0% | -19.0% |
| June 30, 2024 | -$1.97M | +6.3% | +15.2% |
| March 31, 2024 | -$2.33M | +10.6% | -20.8% |
| September 30, 2023 | -$1.93M | +36.4% | +8.6% |
| June 30, 2023 | -$2.11M | +21.0% | +19.1% |
- Quoin Pharmaceuticals, Ltd. showed a decrease of -76.3% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Quoin Pharmaceuticals, Ltd.’s net income has declined by 912.9% (from -$1.56 million to -$15.80 million).
- The most recent figure is from Quoin Pharmaceuticals, Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: